Literature DB >> 35221862

Blood Groups and Their Correlation with Hereditary Disease.

Christoph Gassner1, Franz F Wagner2,3.   

Abstract

Entities:  

Year:  2022        PMID： 35221862      PMCID： PMC8832200          DOI： 10.1159/000521418

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  12 in total

1.  The molecular genetics of the human I locus and molecular background explain the partial association of the adult i phenotype with congenital cataracts.

Authors:  Lung-Chih Yu; Yuh-Ching Twu; Ming-Lun Chou; Marion E Reid; Alan R Gray; Joann M Moulds; Ching-Yi Chang; Marie Lin
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

2.  A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient.

Authors:  Markus Anliker; Inge von Zabern; Britta Höchsmann; Henriette Kyrieleis; Christian Dohna-Schwake; Willy A Flegel; Hubert Schrezenmeier; Christof Weinstock
Journal:  Transfusion       Date:  2014-01-03       Impact factor: 3.157

3.  Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2.

Authors:  Sven Jäckel; Klytaimnistra Kiouptsi; Maren Lillich; Tim Hendrikx; Avinash Khandagale; Bettina Kollar; Nives Hörmann; Cora Reiss; Saravanan Subramaniam; Eivor Wilms; Katharina Ebner; Marie-Luise von Brühl; Philipp Rausch; John F Baines; Sandra Haberichter; Bernhard Lämmle; Christoph J Binder; Kerstin Jurk; Zaverio M Ruggeri; Steffen Massberg; Ulrich Walter; Wolfram Ruf; Christoph Reinhardt
Journal:  Blood       Date:  2017-06-01       Impact factor: 22.113

4.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

5.  Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation.

Authors:  Slim Azouzi; Mahmoud Mikdar; Patricia Hermand; Emilie-Fleur Gautier; Virginie Salnot; Alexandra Willemetz; Gaël Nicolas; Cédric Vrignaud; Alexandre Raneri; Patrick Mayeux; Christine Bole-Feysot; Patrick Nitschké; Jean-Pierre Cartron; Yves Colin; Olivier Hermine; Gabriele Jedlitschky; Marc Cloutier; Jessica Constanzo-Yanez; Carole Ethier; Nancy Robitaille; Maryse St-Louis; Caroline Le Van Kim; Thierry Peyrard
Journal:  Blood       Date:  2020-02-06       Impact factor: 22.113

6.  Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.

Authors:  M Ho; J Chelly; N Carter; A Danek; P Crocker; A P Monaco
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

7.  Novel pathogenic XK mutations in McLeod syndrome and interaction between XK protein and chorein.

Authors:  Yuka Urata; Masayuki Nakamura; Natsuki Sasaki; Nari Shiokawa; Yoshiaki Nishida; Kaoru Arai; Hanae Hiwatashi; Izumi Yokoyama; Shinsuke Narumi; Yasuo Terayama; Takenobu Murakami; Yoshikazu Ugawa; Hiroki Sakamoto; Satoshi Kaneko; Yusuke Nakazawa; Ryo Yamasaki; Shoko Sadashima; Toshiaki Sakai; Hiroaki Arai; Akira Sano
Journal:  Neurol Genet       Date:  2019-04-22

Review 8.  ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis.

Authors:  Marta Gutiérrez-Valencia; Leire Leache; Julián Librero; Carlos Jericó; Mónica Enguita Germán; Jose Antonio García-Erce
Journal:  Transfusion       Date:  2021-11-19       Impact factor: 3.337

9.  XK is a partner for VPS13A: a molecular link between Chorea-Acanthocytosis and McLeod Syndrome.

Authors:  Jae-Sook Park; Aaron M Neiman
Journal:  Mol Biol Cell       Date:  2020-08-26       Impact factor: 4.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.